| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,226 |
3,818 |
$1.40M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,823 |
4,526 |
$1.19M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,414 |
1,319 |
$805K |
| OP272 |
|
842 |
816 |
$221K |
| OP710 |
|
427 |
416 |
$210K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,514 |
2,270 |
$204K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
846 |
811 |
$156K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,972 |
2,765 |
$138K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,593 |
1,479 |
$116K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,568 |
1,325 |
$116K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,679 |
1,388 |
$115K |
| 70450 |
Computed tomography, head or brain; without contrast material |
313 |
290 |
$105K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
952 |
880 |
$100K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,111 |
1,048 |
$92K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,806 |
4,174 |
$91K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
217 |
211 |
$87K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
212 |
210 |
$85K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
483 |
453 |
$80K |
| OP250 |
|
8,166 |
6,871 |
$70K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
577 |
144 |
$48K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,854 |
1,667 |
$47K |
| 80053 |
Comprehensive metabolic panel |
4,287 |
3,910 |
$43K |
| 71045 |
Radiologic examination, chest; single view |
1,490 |
1,411 |
$40K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
265 |
220 |
$37K |
| 71046 |
Radiologic examination, chest; 2 views |
1,247 |
1,218 |
$34K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
92 |
91 |
$32K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
321 |
312 |
$31K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
231 |
210 |
$31K |
| 86900 |
|
1,290 |
1,218 |
$30K |
| 86850 |
|
1,116 |
1,055 |
$27K |
| 86901 |
|
1,289 |
1,217 |
$26K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
128 |
107 |
$15K |
| 84484 |
|
978 |
840 |
$10K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
58 |
56 |
$10K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
28 |
27 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
902 |
877 |
$9K |
| 81025 |
|
2,612 |
2,454 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
818 |
690 |
$7K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
268 |
240 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
259 |
247 |
$6K |
| J2704 |
Injection, propofol, 10 mg |
809 |
786 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
85 |
72 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
75 |
71 |
$5K |
| 93017 |
|
28 |
28 |
$5K |
| 82962 |
|
1,098 |
811 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
662 |
643 |
$4K |
| 85027 |
|
736 |
693 |
$4K |
| OP258 |
|
604 |
485 |
$4K |
| 88342 |
|
37 |
37 |
$3K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
23 |
23 |
$3K |
| 83690 |
|
716 |
676 |
$3K |
| 85610 |
|
1,116 |
1,073 |
$3K |
| 81001 |
|
2,548 |
2,426 |
$3K |
| 83735 |
|
681 |
549 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
65 |
56 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,430 |
1,251 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
27 |
27 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
212 |
211 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
29 |
26 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,459 |
1,310 |
$2K |
| 84702 |
|
167 |
137 |
$2K |
| 90686 |
|
328 |
328 |
$1K |
| 59025 |
Fetal non-stress test |
13 |
13 |
$1K |
| 85730 |
|
663 |
596 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,186 |
1,040 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
26 |
26 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
26 |
26 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
541 |
480 |
$1K |
| 81003 |
|
553 |
534 |
$840.94 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
105 |
102 |
$814.24 |
| 84100 |
|
250 |
171 |
$782.20 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
25 |
25 |
$765.78 |
| 73610 |
|
14 |
12 |
$716.79 |
| 80061 |
Lipid panel |
45 |
45 |
$710.50 |
| J3490 |
Unclassified drugs |
526 |
457 |
$689.54 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
53 |
53 |
$673.20 |
| A4649 |
Surgical supply; miscellaneous |
108 |
106 |
$632.93 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
599 |
583 |
$623.92 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
12 |
12 |
$515.68 |
| 87522 |
Neg quan hep c or qual rna |
25 |
25 |
$470.72 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
28 |
12 |
$457.94 |
| 87070 |
|
47 |
47 |
$443.54 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
363 |
333 |
$389.68 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
391 |
385 |
$356.18 |
| 82077 |
|
29 |
27 |
$288.77 |
| 90715 |
|
13 |
13 |
$281.43 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
73 |
62 |
$275.44 |
| 80076 |
|
28 |
24 |
$201.25 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
26 |
26 |
$167.98 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
41 |
25 |
$102.10 |
| A0425 |
Ground mileage, per statute mile |
12 |
12 |
$101.40 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
86 |
68 |
$69.27 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
14 |
12 |
$37.16 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
34 |
24 |
$34.85 |
| 90633 |
|
13 |
13 |
$0.00 |
| 90670 |
|
12 |
12 |
$0.00 |